InvestorsHub Logo
Followers 20
Posts 1135
Boards Moderated 0
Alias Born 11/21/2017

Re: None

Tuesday, 11/21/2017 4:26:34 PM

Tuesday, November 21, 2017 4:26:34 PM

Post# of 698817
I've been monitoring this board for a while. I've done my homework on NWBO, read lots of independent analysis, and I like the science of cancer immunotherapy. I really think DCVAX has a great chance at efficacy on GBM, but like any investor here, I worry about the company's financial position. I especially appreciate what some of the statisticians have put on here, especially the AlphaPuppy. We are fortunate to have the blinded data from ASCO last June as a guide. But the largest point that keeps echoing in my analysis is Dr. Liau's message that the longer this study goes, the better the chance of efficacy. I'd say the phase III study has gone on long enough to prove her point. As for lack of communication from NWBO management, well, if this stock is being manipulated by shorts, the best thing to say is nothing. Let the data mature, the science play out, and the shorts get burned by the results. GBM could be the just tip of the cancer iceberg for DC immunotherapy and combo trials could prove to be greatly effective. Profits will follow efficacy, if proven. This security could be the rocket on a launching pad.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News